Biologic Therapies for Severe Asthma
In this Allergy, Inflammation and Immunology Assembly podcast, Dr. Jose Gomez interviews Dr. Sumita Khatri Associate Professor of Medicine at CCLCM/CWRU School of Medicine and co-director of the asthma center at the Cleveland clinic. Their conversation is focused on patient selection, differences between omalizumab, mepolizumab and reslizumab, and practical aspects of biologic therapies for severe asthma.
*If you are unable to play the audio please click here to download the file.
